stella
beta
A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults — Stella
Recruiting
Back to Healthy trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Australia
Veritus Research, Bayswater, Victoria
View full record on ClinicalTrials.gov